Globus Medical (GMED) said Wednesday it expects Q4 sales of about $657 million, up from $616.5 million a year earlier.
Analysts polled by FactSet expect $635.5 million.
The company said 2024 sales are expected to be about $2.52 billion.
Analysts surveyed by FactSet expect $2.5 billion.
Globus expects 2025 revenue of $2.66 billion to $2.69 billion and diluted non-GAAP earnings of $3.40 to $3.50 a share.
Analysts polled by FactSet expect revenue of $2.66 billion and EPS of $3.42.
Globus shares rose 2.8% in recent after-hours trading.
Price: 89.00, Change: +2.45, Percent Change: +2.83
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。